We use analytics and advertising cookies, which you can accept or reject; see our privacy policy.

Current choice:

Cyclophilin

Cyclophilin inhibitors and ligands target cyclophilins, prolyl isomerases that bind cyclosporin A. Cyclophilin was identified in 1984 as the cytosolic protein that binds this immunosuppressant. In 1991 the cyclophilin and cyclosporin A complex was shown to inhibit the phosphatase calcineurin, which explains the immunosuppressive action. Alisporivir and NIM811 are cyclosporin analogs that bind cyclophilins but do not inhibit calcineurin. Cyclosporin C is a natural member of the cyclosporin family, and Cyclophilin inhibitor 1 is described as a cyclophilin A inhibitor. The set also includes RAS inhibitors such as RMC-7977 and elironrasib. These compounds form a tri-complex with cyclophilin A and active RAS, a mechanism reported in 2023.

1 Item

  • Ganoderic acid D
    Cat. No.
    A30307
    CAS No.
    108340-60-9

    Ganoderic acid D

    Ganoderic Acid D is a tetracyclic triterpenoid derived from Ganoderma lucidum, known for its role as an apoptosis inducer. This compound facilitates the upregulation of SIRT3 protein expression, leading to enhanced deacetylation of cyclophilin D (CypD). Ganoderic Acid D effectively disrupts energy metabolism in colon cancer cells by inhibiting glucose uptake, lactate production, and the synthesis of pyruvate and acetyl-CoA. Additionally, it demonstrates potent apoptotic effects in HeLa human cervical carcinoma cells, making it a valuable reagent for cancer research applications.

    In stock View Details
    1 mg
    $40.00
    5 mg
    $105.00
    All 4 sizes

1 Item

Added to your cart

View Cart Checkout

    Loading...